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TCT-535
Correlation of Toe-Brachial Indices with Infragenicular Arterial Patency in
Critical Limb Ischemia
Jessen Jacob1, Matthew C. Bunte1, Michael Maier1, Mehdi Shishehbor1
1Cleveland Clinic, Cleveland, OH
Background: Current ACC/AHA guidelines recommend toe-brachial indices (TBI)
for diagnosis of peripheral arterial disease when ankle-brachial indices are unreliable
due to non-compressible vessels. We sought to investigate how well TBI correlates
with Rutherford classiﬁcation and infragenicular arterial patency in critical limb
ischemia (CLI).
Methods: Between July 2011 and February 2013, among patients who presented to
the Cleveland Clinic Lower Extremity Wound Clinic with Rutherford Category 4-6
symptoms, 41 patients had TBI and lower extremity angiography performed. The
correlation between TBI, Rutherford Category, and infragenicular arterial patency was
evaluated.
Results: The median TBI for Rutherford Category 4, 5, and 6 symptoms was
0.320.25 (SD), 0.240.29 (SD), and 0.300.20 (SD), respectively. The median TBI
for 0, 1, 2, and 3-vessel runoff was 0.250.36 (SD), 0.260.21 (SD), 0.290.20
(SD), and 0.430.29 (SD), respectively. There was no statistically signiﬁcant
difference between TBI and Rutherford category (p¼0.42) or number of patent runoff
vessels below the knee (p¼0.80).Conclusions: In a small population of patients, TBI had a non-signiﬁcant correlation
with infragenicular runoff. TBI did not correlate with Rutherford classiﬁcation.
Patients with a high index of clinical suspicion for CLI should undergo further
angiographic evaluation when revascularization may improve outcomes.
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Pooled Analysis of the CONFIRM Registries: Outcomes in Elderly Patients
Treated with Orbital Atherectomy for Peripheral Arterial Disease
Michael Lee1
1UCLA Medical Center, Los Angeles, CA
Background: The elderly represent a growing population of patients in the
community. There is a paucity of data about the outcomes of elderly patients with
peripheral arterial disease who undergo orbital atherectomy.
Methods: Our analysis of the CONFIRM I-III registries includes 2995 real-world
patients (4557 lesions) with 1753 patients <75 years of age (2637 lesions) and 1753
patients 75 years of age (1920 lesions) treated with orbital atherectomy. The primary
endpoint was the composite of dissection, perforation, slow ﬂow, vessel closure,
spasm, embolism, and thrombus formation.
Results: Patients 75 years of age had a high proportion of females (47.5% vs.
35.3%, p<0.001), more patients with critical limb ischemia, longer mean lesion length
(75.0  74.1 vs. 69.9  68.9 mm, p¼0.01), and more treatment location below the
knee 38.4% vs. 34.1%, p<0.001). Patients <75 years of age and 75 years of age had
similar rates of the primary end point (22.0% vs. 21.3%, p¼0.81), dissection (11.4%
vs. 10.5%, p¼0.72), vessel closure (1.7% vs. 1.1%, p¼0.13), spasm (6.3% vs. 6.4%,
p¼0.96), and embolism (2.5% vs. 1.6%, p¼0.31). Patients 75 years of age had less
incidence of thrombus formation (0.9% vs. 1.6%, p¼0.03) but higher perforation rate
(1.2% vs. 0.4%, p¼0.007) and a trend towards a higher rate of slow ﬂow (5.3% vs.
4.0%, p¼0.08).
Conclusions: Plaque modiﬁcation with orbital atherectomy provided similar clinical
outcomes in the patients <75 years of age and 75 years of age despite the elderly
having unfavorable baseline clinical and lesion characteristics including more patients
with critical limb ischemia, longer lesions, and treatment below the knee. The higher
rates of perforation and trend towards increased slow ﬂow may be explained by more
extensive disease and smaller vessels.B162 JACC Vol 62/18/Suppl B j October 27–NTCT-537
Long-term Outcomes of Self-Expanding Nitinol Stent Implantation for Chronic
Total Occlusion of the Superﬁcial Femoral and Proximal Popliteal Artery
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Background: Although recent guideline show expanded indication of endovascular
therapy (EVT) for superﬁcial femoral and proximal popliteal artery (SFPA) lesion,
only secondary patency rate after self-expanding nitinol stent implantation is
comparable for vein-graft bypass. Long-term outcomes are necessary for stent
implantation to be considered as ﬁrst-line therapy. This study investigated the long-
term patency rates and predictors of restenosis after self-expanding nitinol stent
implantation for chronic total occlusion (CTO) in SFPA lesions.
Methods: From January 2004 to December 2011, 2742 patients with peripheral artery
disease of SFPA lesion 3471 limbs underwent EVT with a self-expanding nitinol stent
at 13 institutions in Japan. Of the cohort, 1036 patients, 1169 limbs, had stents
implanted for CTOs in the SFPA and were followed as long as 8 years (mean
899607 days). We retrospectively investigated baseline characteristics, patency
rates, clinical outcomes and predictors of loss of primary patency.
Results: Mean age was 739 years and 28% were female patients. Fifty-nine percent
of the patients had diabetes mellitus and 27% were patients with critical limb
ischemia. Occluded length was 18485 mm, 74% was TASC II type C, D lesion.
Mean total stent length was 20389 mm and mean stent diameter was 6.70.8 mm,
mean ﬁnal balloon diameter was 5.20.8 mm. Fifty-two percent administrated cil-
ostazole. Incidence of stent fracture was 6%. Primary, assisted primary, secondary
patency rates were 42%, 63%, 76%, respectively. Mortality rate was 14%, 2.5% went
to surgical bypass, 2.7% had major amputation. In the multivariate analysis, stent
fracture (OR 2.52; p¼0.0016), female gender (OR 1.73; p¼0.0005), use of distal
puncture technique (OR 1.50; p¼0.0096), diabetes mellitus (OR 1.43; p¼0.0148),
ﬁnal balloon diameter (OR 0.23; p¼0.0075), administration of cilostazol (OR 0.65;
p¼0.0052) and use of IVUS (OR 0.71; p¼0.0342) were factors strongly associated
with loss of primary patency.
Conclusions: Although primary patency was low, secondary patency rate was
acceptable.
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Catheter directed thrombolysis in deep venous thrombosis with or without
pulmonary thromboembolism
Maddury Jyotsna1, Abhisheka K. Tripathi2
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Background: As deep venous thrombosis (DVT) treatment with anticoagulation does
not resolve the thrombus formed in the vein, we wanted to study the result of catheter
directed thrombolysis (CDT) in patients with acute DVT with or without pulmonary
thromboembolism (PTE).
Methods: We retrospectively analysed the data of patients who presented with acute
(< 10 days) or sub-acute (< 21 days) or acute on chronic DVT with or without PTE
and were given CDT through Multi-Side port Catheter Infusion Sets Dual Check
Valve 5F perfusion catheter (65 or 100cm from Cook's company), in our unit in the
year 2012. CDT was done with streptokinase, 250,000 U as a loading dose over 30
minutes, followed by 100,000 U/h over 24 hours. CT pulmonary angio and venous
colour Doppler was done before and 24 hrs after CDT was done. Success of CDT was
deﬁned as complete or partial depending on complete or reduction of thrombus burden
in pulmonary arteries &/or deep veins.
Results: A total of 22 patients presented with Acute DVT in our unit [15 (68.2%)
males and 7 (31.8%) females with mean age of 42.6  13.6 yrs ] in 2012. Out of
them 11 (50%) had PTE, 6 massive and 5 sub massive and 9 had PAH . 14(63.6%)
had Acute, 4 (18.2%) had sub-acute & 4 (18.2%) had acute on chronic DVT. 8
patients had predisposing factors (immobilization 4, adrenal adenoma 1, hyper-
homocysteinemia 1, haemodialysis related 1, venous stenosis 1). Simultaneously
IVC ﬁlter implantation in 12 (54.5%) and venous stenting in one patient was done.
After 24 hrs of CDT , 11 (50%) DVT patients had complete resolution of thrombus
and 11 (50%) had partial resolution (even in this group proximal thrombus in iliac
veins was disappeared in all except one). Out of 11 patients who had PTE, 8 had
complete resolution of thrombus and 3 had partial. Pulmonary artery pressure
normalized in 7 (7/9- 77.8%). In 3 patients IVC ﬁlters were retrieved. One patient had
puncture site hematoma which was managed conservatively. No fatal complication
was noted.ovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention
